Keyphrases
Preeclampsia
100%
First Trimester
100%
Sphingomyelin
100%
Sphingolipidomics
100%
Ceramide
31%
Maternal Plasma
25%
Sphingolipids
25%
Preeclamptic
18%
Dihydrosphingosine-1-phosphate
18%
Plasma Samples
12%
Ceramide Species
12%
Sphingosine-1-phosphate
12%
Bioactive Sphingolipids
12%
Etiopathogenesis
6%
Proteinuria
6%
Fetal Morbidity
6%
Third Trimester
6%
Second Trimester
6%
Pregnancy Trimester
6%
Control Subjects
6%
Premature Birth
6%
Early Prediction
6%
Early Biomarker
6%
Stratified Study
6%
Fetal Mortality
6%
Maternal Morbidity
6%
Angiogenic
6%
Metabolic Syndrome
6%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
6%
Plasma Parameters
6%
Second Trimester of Pregnancy
6%
Generalized Edema
6%
Disease Development
6%
Gestational Disorders
6%
Plasma Sphingolipids
6%
Maternal Hypertension
6%
Sphingolipid Ceramide
6%
Plasma Ceramides
6%
Reversed-phase HPLC
6%
Electrospray Ionization Mass Spectrometry
6%
Molecular Species
6%
HPLC-ESI-MS
6%
Potential Contribution
6%
Human Plasma
6%
Angiogenic Imbalance
6%
Endothelial Barrier
6%
Biochemical Profile
6%
Biochemistry, Genetics and Molecular Biology
First Trimester Pregnancy
100%
Blood Plasma
100%
Sphingomyelin
100%
Ceramide
50%
Sphingolipid
43%
Pregnancy
31%
Sphingosine-1-Phosphate
31%
Second Trimester Pregnancy
12%
Blood Level
6%
Third Trimester Pregnancy
6%
High-Performance Liquid Chromatography
6%
Tandem Mass Spectrometry
6%
Liquid Chromatography-Mass Spectrometry
6%
Upregulation
6%
Reverse Phase High Performance Liquid Chromatography
6%
Electrospray Ionization
6%
Molecule
6%